CD8A and neoplasm: As such, tumor cells efficiently disrupt the methionine metabolism in CD8+ T cells, resulting in decreased methyl donor S-adenosylmethionine (SAM) and dimethylation of histone H3 (H3K79me2), impairing T cell immunity [22].